In the Globe and Mail article by Jeff Gray, "Supreme Court Backs Glaxo in Transfer-Pricing Dispute", Claire Kennedy comments on the Supreme Court of Canada decision that dismissed the federal government's claim the pharmaceutical company owed millions in unpaid taxes and upheld GlaxoSmithKline's current transfer pricing practices. "This does not give taxpayers carte blanche, at all," says Claire Kennedy. "...It's not as though it's creating a huge opening in terms of transfer pricing."